Ronald Harold Wilfred Cooper - 22 Apr 2022 Form 4 Insider Report for ALBIREO PHARMA, INC.

Role
President and CEO, Director
Signature
/s/ Jason Duncan, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
22 Apr 2022
Net transactions value
-$30,031
Form type
4
Filing time
25 Apr 2022, 16:40:29 UTC
Previous filing
25 Jan 2022
Next filing
13 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALBO Common Stock Sale $30,031 -907 -1.6% $33.11 56,082 22 Apr 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.
F2 Represents 22,600 shares of common stock and 33,482 restricted stock units.